Organogenesis Holdings (ORGO) Assets Average (2016 - 2026)

Organogenesis Holdings' Assets Average history runs 11 years deep, the most recent figure standing at $559.4 million for Q1 2026.

• On a quarterly basis, Assets Average rose 15.9% year-over-year to $559.4 million in Q1 2026; TTM through Mar 2026 was $559.4 million, a 15.9% increase from a year earlier, with the FY2025 full-year figure at $548.3 million, up 14.48% from the prior year.
• Assets Average rose to $559.4 million in Q1 2026 per ORGO's latest filing, from $554.3 million in the prior quarter.
• Across five years, Assets Average topped out at $559.4 million in Q1 2026 and bottomed at $439.8 million in Q1 2022.
• The 5-year median for Assets Average is $456.8 million (2022), against an average of $469.6 million.
• Across the five-year window, Assets Average surged 44.33% in 2022 and decreased 2.57% in 2024, its largest moves.
• Year by year, Assets Average stood at $453.3 million in 2022, then increased by 1.77% to $461.3 million in 2023, then advanced by 2.33% to $472.1 million in 2024, then gained by 17.41% to $554.3 million in 2025, then increased by 0.92% to $559.4 million in 2026.
• Per Business Quant, the three latest ORGO Assets Average figures stand at $559.4 million (Q1 2026), $554.3 million (Q4 2025), and $485.5 million (Q3 2025).